- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Knox Lane–Backed Fingerpaint Acquires Emcay, Expanding Company’s Multicultural Capabilities
Fingerpaint Marketing, Inc. announced the acquisition of Emcay, LLC, a full-service agency uniquely designed to provide a perfect balance of pharmaceutical knowledge and multicultural insight, and the creation of Fingerpaint Multicultural, a specialty offering that will focus solely on Pharmacultural® marketing. In December 2020, Fingerpaint partnered with San Francisco–based private equity firm Knox Lane to accelerate its trajectory through organic growth and strategic partnerships.
Fingerpaint Multicultural will fall under the Fingerpaint Marketing brand and tap into both companies’ multicultural expertise.
Pharmacultural® marketing is the basis for a proprietary approach to rethinking and distilling unique cultural insights into actionable and authentic content and campaigns, no matter the therapeutic area, channel, or customer type.
Transforming Cancer Care: Data, AI, and Patient-Centered Care
July 20th 2023Join us as Mohit Manrao, SVP and head of US oncology at AstraZeneca, shares his patient-centered approach to transforming cancer care, bridging the gap between innovative science and tangible patient outcomes across all populations on a global scale.
